January 21, 2021
Study sites are in five African countries with high TB and HIV burden.
Features
January 19, 2021
IAVI to participate in major HIV prevention research conference beginning January 27
IAVI recognizes the European & Developing Countries Clinical Trials Partnership (EDCTP) for its continued commitment to supporting Europe and sub-Saharan Africa ...
This World AIDS Day, 2020 AVAC Advocacy Fellow Winifred Ikilai shares her a community perspective on the need to ensure globally accessible ...
November 9, 2020
IAVI welcomes evidence of long-acting cabotegravir’s safety and efficacy in cisgender women.
November 6, 2020
The study will assess the safety, tolerability, and immunogenicity of SARS-CoV-2 vaccine candidate V590 compared to placebo.
October 23, 2020
There are more than 70 different mAbs in various stages of development for the treatment and prevention of COVID-19, including those discovered ...
October 8, 2020
Monoclonal antibodies have changed the way we treat many diseases. They are a promising treatment for COVID-19, and IAVI is committed ...
September 28, 2020
Resulting knowledge and capacity continue to advance HIV vaccine research globally
September 22, 2020
Expert insights on a range of issues related to COVID-19, including media communication, community engagement, and mental health
Raising awareness of one of the world’s biggest hidden health crises
Show More
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
